Welcome to our dedicated page for Advanced Health Intelligence Ltd. American Depositary Shares news (Ticker: AHI), a resource for investors and traders seeking the latest updates and insights on Advanced Health Intelligence Ltd. American Depositary Shares stock.
Advanced Health Intelligence Ltd (AHI), listed on both the ASX and NASDAQ under the symbol AHI, is a pioneer in the realm of digital health. The company specializes in delivering scalable health assessments and risk stratification through proprietary technology accessible via smartphones. Their main services include biometric scans that provide vital signs and health risk estimates for individuals. AHI's technology leverages computer vision, machine learning models, and patented algorithms to offer secure and user-friendly health assessments.
AHI has developed a comprehensive suite of health assessment tools designed for healthcare providers, insurers, employers, and government agencies. These tools include:
- Body dimension and composition assessments: Identifying obesity-related comorbidities like diabetes.
- Blood biomarker prediction: Estimating levels of HbA1C, HDL, LDL, and projecting a 10-year mortality risk.
- Transdermal Optical Imaging: Providing vital signs and cardiovascular disease risk estimates.
- On-device dermatological skin identification: Capable of recognizing 588 skin conditions across 133 categories, including Melanoma.
AHI's solutions are acclaimed for their scalability and ease of use, making health assessments accessible anytime and anywhere. The company continuously enriches its offerings through strategic collaborations and partnerships worldwide, such as recent agreements in Vietnam with OneClinic and in the Middle East with Dr. Walid Abbas Zaher. Furthermore, AHI’s collaborations with insurance companies like Unisure and innovative projects like the Bearn partnership in the USA demonstrate its extensive market reach and adaptability.
The company’s innovative Biometric Health Assessment (BHA) via smartphone encapsulates several key steps:
- FaceScan: Determines blood pressure risk zones and gathers demographic and lifestyle data.
- Photoplethysmogram (PPG) Resting Heart Rate Measurement: Captures resting heart rate to evaluate baseline heart health.
- BodyScan: Produces waist and hip circumference and body fat percentage.
- Cardiovascular Fitness Evaluation: Assesses cardiovascular fitness through an exertion test and heart rate recovery monitoring.
By integrating these steps, AHI provides an immediate, comprehensive health risk assessment, making it an invaluable tool for early detection and management of chronic diseases.
In summary, Advanced Health Intelligence Ltd stands at the forefront of health-tech innovation, committed to improving global health outcomes and enhancing health literacy. Through their robust technology and strategic collaborations, AHI aims to revolutionize digital health care on a global scale.
Advanced Human Imaging Ltd (ASX, NASDAQ: AHI) has completed a Master Services Agreement with South Africa-based VERTICA Pty Ltd. This agreement allows Vertica to use AHI’s Software Development Kits (SDKs) for body circumference and face scan measurements, enhancing their digital health platform. The MSA includes service and technology support, but the financial impact on AHI is currently unquantifiable, as no minimum orders are set. AHI expects no immediate financial return, with revenue identifiable only after the commercial release of the integrated application.
Advanced Human Imaging Limited (ASX, NASDAQ: AHI) has finalized a Master Services Agreement (MSA) with Singapore's BIZBAZ Pte Ltd. This arrangement permits BizBaz to utilize AHI's Software Development Kits for body and face measurements within their application. The MSA is set for an initial term of one year, with automatic renewals. While the financial implications are currently unquantifiable, there are no minimum order commitments. AHI will provide technology support and training under this agreement, but integration timelines depend on BizBaz's technical readiness.
Advanced Human Imaging (ASX: AHI) has signed a Master Services Agreement with NEXTMEDICALL S.A.C, allowing the integration of AHI's MultiScan SDK into Nextmedicall's platform. This partnership aims to enhance telemedicine services in Latin America, providing users with tools to assess health risks and vital signs. The MSA covers essential aspects including software development, technology support, and data processing. Nextmedicall specializes in connecting chronic disease patients with healthcare providers, creating a comprehensive digital health solution.
Advanced Human Imaging Limited (ASX: AHI) announced a letter to shareholders from new CEO Dr. Katherine Iscoe, emphasizing a commitment to driving growth and innovation. She outlined plans to enhance AHI's technology, strengthen customer engagement, and improve revenue strategies. Acknowledging challenges such as a low share price, Iscoe aims to align her leadership with shareholder interests, aiming for transformative advancements in health tech using smartphone capabilities. Under her guidance, AHI seeks to expand its presence in various sectors, including health and fitness.
FAQ
What is the market cap of Advanced Health Intelligence Ltd. American Depositary Shares (AHI)?
What does Advanced Health Intelligence Ltd (AHI) specialize in?
What kind of health assessments does AHI offer?
How does AHI’s Biometric Health Assessment (BHA) work?
What are some recent strategic collaborations of AHI?
How is AHI’s technology beneficial for chronic disease management?
What is AHI's mission?
What are some unique features of AHI’s health assessments?
Which regions is AHI currently focusing on for expanding its services?
How does AHI ensure the privacy and security of health data?
Can individuals use AHI’s health assessments on their own?
